The past decade has been witness to a renaissance in psychedelics research. Studies suggest some of these drugs can safely benefit people with psychological problems when paired with therapy. Dr. Elizabeth Nielson is a psychologist and psychedelics researcher. She’s a therapist on FDA-approved clinical trials of psilocybin-assisted treatments of alcohol use disorder, treatment-resistant depression, and MDMA-assisted treatment of PTSD. She’s also the co-founder of Fluence, an independent training institute for the integration of psychedelic experiences in clinical settings.
News Types: